Pulmonary Fibrosis Research at Weill Cornell Medical College

10/01/2013

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis (RAINIER) Principal Investiga...

01/14/2013

The PANTHER study is now closed to enrollment. A new pulmonary fibrosis study will be opening soon. Information on the new study will be posted here when it is open to enrollment.

07/26/2011

Click here to learn more about the PANTHER study, currently enrolling at Weill Cornell Medical Center.

The purpose of the PANTHER study is to find out how effective the drug N-acetylcysteine (NAC), alone and in combination with prednisone and azathioprine, is at preventing the loss of lung function in people with Idiopathic Pulmonary Fibrosis (IPF).

06/16/2011

My husband Bill is in the late stages of pulmonary fibrosis, a lung disease with no known cure. This is our story of our journey through the disease and how it has affected one family's life.

06/09/2011

Weill Cornell Pulmonary Associates specializes in all aspects of Pulmonary Disease. Our skilled physicians provide the most up-to-date treatment available in a state-of-the-art medical facility.

06/08/2011

The ACE-IPF study is now closed to enrollment. The PANTHER study is still open to enrollment at Weill Cornell Medical Center.

02/16/2011

Welcome to the Clinical Trials site for the Department of Medicine at New York-Presbyterian Hospital/Weill Cornell Medical College.

10/26/2010

09/27/2010

Pulmonary Fibrosis Advocates Increase Co-Sponsors of Research Act Following Lobbying in Washington.

09/08/2010

/PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) kicks off the 8th annual National Pulmonary Fibrosis (PF) Awareness Week Sept. 11 to 18. The primary goals of this year's activity are to ensure passage of the Pulmonary Fibrosis Research Enhancement Act (PFREA), in the Senate and...

09/05/2010

Coalition for Pulmonary Fibrosis Urges Patients to Consider Clinical Trials Including Two New Ones Funded By the NIH.

07/06/2010

Living with Idiopathic Pulmonary Fibrosis

There's no cure for idiopathic pulmonary fibrosis (IPF) yet.